Showing results (1-10 of 223) with videos related to
Sort By:
Pageof 23
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 20, 2015
Determination of True ERBB2 Gene Amplification in Breast Cancer by Quantitative PCR Using a Reference and a Novel Control GeneCristina Chamizo, Federico Rojo, Juan Madoz-GúrpideWorld Journal of Surgery|June 1, 2017
Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal CancerBlanca Torrejón, Ion Cristóbal, Federico Rojo, et al.Molecular and Cellular Biology|April 20, 2016
Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic ImplicationsIon Cristóbal, Federico Rojo, Juan Madoz-Gúrpide, et al.Seminars in Diagnostic Pathology|November 19, 2008
Targeted therapies in breast cancerFederico Rojo, Joan Albanell, Ana Rovira, et al.The EMBO Journal|February 28, 2003
TACE is required for the activation of the EGFR by TGF-alpha in tumorsMaria Borrell-Pagès, Federico Rojo, Joan Albanell, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2008
Genetic changes in small cell lung carcinomaEdurne Arriola, Israel Cañadas, Montse Arumí, et al.NPJ Breast Cancer|May 15, 2026
Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancerCaterina Marchiò, Federico Rojo, Ellen R Copson, et al.Cancers|July 30, 2020
MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic ValueLaura Imedio, Ion Cristóbal, Jaime Rubio, et al.Cancers|March 27, 2019
The Role of MicroRNAs in Hepatoblastoma TumorsIon Cristóbal, Marta Sanz-Álvarez, Melani Luque, et al.Oncoimmunology|March 5, 2016
Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsJosé Yélamos, Miguel Galindo, Judith Navarro, et al.Pageof 23